Dr Benjamin Guix Prostate Cancer Breast Cancer Treatment Professor Doctor Benjamin Guix Brachytherapy radiotherapy IMRT IGRT Barcelona Spain

NEWS

Return to the English home page http://www.imor.org/index_ang.htm

Return to the home page http://imor.org/index.htm

Consultar la web en español http:www.imor.org

Consultar noticias en español contenido3_cast.htm

Consultar la web en català http://www.imor.org/index_cat.htm

Consultar noticies en català contenido3_cat.htm

Links related LINKS IMOR.htm

CV professor Dr Benjamín Guix MD PhD MBA Professor_Dr_Benjamin_Guix_CV.pdf Profesor_Doctor_Benjamin_Guix_Melcior_CV_es.pdf Profesor_Doctor_Benjamin_Guix_Melcior_CV_ct.pdf Profesor_Dr_Benjam_n_Guix_CV.pdf www.telefonica.net/web2/benjaminguix www.telefonica.net/web/bguix

· Older men who opt for treatment for their prostate cancer are doing much better than partients who underwent watchful waiting. The article reports that older men who undergo active treatments for prostate cancer instead of monitor the disease’s progression, had a risk of diying by any cause nearly one-third lower than the patients who received no-treatment. 1 Rethinking Prostate Cancer in Older Men.doc (www.telefonica.net/web2/benjaminguix www.telefonica.net/web/bguix)

· Nicotin boosts cancer metastases. This article disusses a Cancer Research study, finding that nicotine may promote breast and prostate cancer metastases. Researchers found that cellular receptors on both breast and prostate eptithelial-like cells and breast or prostate tumor cells, when bound to nicotine, activate a molecular pathway signaling cell growth. Dr Benjamin Guix reports. 1 Nicotine May Spur Breast Cancer.doc (www.telefonica.net/web2/benjaminguix www.telefonica.net/web/bguix)

· The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, presents a revolutionary treatment for prostate cancer. The event was hosted by Professors Dr Benjamin Guix Melcior, Director of the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, and Dr Jose Maria Bartrina, urologist. Treatment consists in combining Image Guided Intensity modulated Radiotherapy IGRT/IMRT with Brachytherapy. Treatment is indicated for patients with localized prostate cancer and is done in an out-patient basis. The IMOR Foundation has an experience of more that 850 patients treated during 10 years. The results has been presented in the International Meeting for Genyto-urinary cancer, held in San Francisco (USA). The IMOR Foundation is a non-profit institution dedicated to offer cancer patients the best treatment world-wide. (www.telefonica.net/web2/benjaminguix www.telefonica.net/web/bguix)

· The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, presents the best treatment for prostate cancer. The event was hosted by Professors Dr Benjamin Guix Melcior, Director of the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, Dr Jose Maria Bartrina, urologist and Dr Jose I Tello, physicist. Treatment is high tech state of the art Image Guided Intensity modulated Radiotherapy IGRT/IMRT with Brachytherapy, either high-dose-rate or low-dose-rate (HDR LDR I125). Treatment is indicated for patients with localized prostate cancer and is done in an out-patient basis. The IMOR Foundation was the first centre in Europe incorporating this technology and is one with the largest experience world-wide. Treatment offers more than 98% cure for prostate cancer. The results has been presented in the International Meeting for Genyto-urinary cancer, held in San Francisco (USA). (www.telefonica.net/web2/benjaminguix www.telefonica.net/web/bguix)

· The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, presents a revolutionary treatment for age related wet macular degeneration (AMD). The The event was hosted by Professors Dr. Borja Corcóstegui, Director of the Ocular Microsurgery Institute (IMO) in Barcelona and Dr Benjamin Guix Melcior, Director of the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, who are serving as a principle investigator for the NeoVista sponsored CABERNET clinical study. Also on the program were John N. Hendrick, President and CEO of NeoVista; Dr. Eugene de Juan, vice chairman of ForSight Labs and co-inventor of the NeoVista technology Brachytherapy in conjunction with the administration of lucentis is the best treatment for AMD. (www.telefonica.net/web2/benjaminguix www.telefonica.net/web/bguix)

I am pleased to serve as a Principle Investigator in the CABERNET Study. A surgical approach to treating this terrible disease is an exciting idea and I look forward to observing the outcomes of this multi-centre trial. , Dr Benjamin Guix stated.

· AMD is one of the most serious conditions that affect the macula (the part of the eye responsible for central vision) and is the main cause of irreparable blindness in people over 60. If left untreated, the condition gives rise to a rapid loss of central best vision. There are currently more than 164,000 people with wet AMD in Spain, and 30,000 new cases are detected every year. These figures are expected to increase in the coming years as the population ages. NeoVista has begun a definitive clinical trial called CABERNET (CNV Secondary to AMD Treated with BEta RadiatioN Epiretinal Therapy) to demonstrate the effectiveness of the NeoVista treatment protocol compared to the results obtained with anti-VEGF therapy alone. This study will recruit 495 patients in 40 clinical sites throughout the world, including the Ocular Microsurgery Institute (IMO) in Barcelona, which will begin its initial treatments in February 2008. The IMOR Foundation and the IMO from Barcelona will be the only Spanish centres treating patients in this extremely important trial. Dr Borja Corcostegui and Dr Benjamin Guix Melcior will serve as principle investigators and responsible of the project.

· To learn more about prostate cancer treatment by IGRT, IMRT and Brachytherapy as best treatment for cancer listen to some of the interview done to Dr Benjamin Guix Melcior, from the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, the best treatment for cancer abroad, cut and paste over the link: http://profesional.medicinatv.com/webcast/muestra.asp?idfg=0&idwc=1387

· The Combined treatment Image-guided Intensity Modulated Radiotherapy (IG-IMRT) plus Prostate Brachytherapy has been demonstrated to be the best approach for intermediate and high risk prostate cancer, as presented today at the World Congress of genito urinary cancer held at San Francisco. The research has been carried-out at The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona, Spain, one of the top place to have the best radiotherapy and brachytherapy abroad, and has been presented by Professor Dr. Benjamin Guix, MD PhD MBA.

· The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, has been invited to participate in the 13^th Puerto Rico Breast Cancer Conference, to expose the recent developments in the treatment of breast cancer and the future perspectives that are now opened. Professor Dr Benjamin Guix MD PhD MBA, Director of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona, Spain, will present the experience of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, in partial breast irradiation, salvage treatment and breast brachytherapy. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, has one the best and longest series of patients treated with these advanced treatments. The IMOR Foundation is considered one of the best place to have cancer treatment abroad and has been awarded twice with the Best ESTRO (European Society for Radiotherapy and Oncology) Award, in 2000 and 2007. At the waterfront of the best treatment for breast cancer.

· The European Society for Radiotherapy and Oncology (ESTRO) has awarded The IMOR Foundation, Medical Institute for Radiotherapy and Oncology at Barcelona (Spain) with the BEST BRACHYTHERAPY AWARD. The price was given to The IMOR Foundation for their contribution to the development of conservative treatment for cancer, mainly prostate cancer. The treatment with brachytherapy, alone or in combination with external beam radiotherapy, has been demonstrated to produce the highest rates of cure, while preserving the Quality of Life at the best. The award was offered to Professor Dr Benjamin Guix, MD PhD MBA, Director of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, by the president of GEC-ESTRO, Erik Van Limbergen, at a Gala Dinner held at Montpellier, during the Celebration of the Annual ESTRO meeting. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, is considered one on the best place to have the treatment of cancer abroad.

· IMRT-Brachytherapy Combined treatment offers the best long-term results in the treatment for intermediate- and high-risk prostate cancer. The 16-year free-from-relapse survival rate was higher than 90%. The results has been published in the International Journal of Radiation Oncology Biology and employed the same protocol used at The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Sapin, since 1.999, said Professor Dr Benjamin Guix. Results are really spectacular with a survival rate unreached with any other technique, even with surgery. PROSTATe_TRAT COMB_ENG.htm

· The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona (Spain), starts treating patients with Image Guided (IGRT) Intensity Modulated Radiotherapy (IMRT) IG-IMRT. This is the first centre employing this technology of southern Europe. The IG-IMRT program is directed by Professor Dr Benjamin Guix with the collaboration of Dr Antonio Arellano, Antonio Martinez, Ferran Guedea, Josep Sole and Manel Algara. IGRT-IMRT is nowadays the best treatment for cancer, and IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, is considered to be the best place to have cancer treatment abroad. JORNADA_IGRT_IMOR_2006_eng.htm

· The IMOR Foundation, Medical Institute for Radiotherapy and Oncology, from Barcelona (Spain), starts treating patients for prostate cancer with Image Guided (IGRT), Intensity Modulated Radiotherapy (IMRT) IG-IMRT, the best and most precise way of radiotherapy and brachytherapy existing today, announced Professor Dr Benjamin Guix. This is the first centre employing this technology of southern Europe, what convert it in the first option to have the best radiotherapy abroad. “This is the most precise and modern way for treating cancer” stated Professor Benjamin Guix, and is applied mainly prostate cancer, lung cancer, head and neck cancer, brain tumors and liver metastases as well as liver cancer. JORNADA_IGRT_IMOR_2006_eng.htm

· The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain has begun the Image Guided Radiotherapy (IGRT), for the first time in Spain, and southern Europe, announced its director Professor Benjamin Guix. This is the best way for treating tumors nowadays, mainly for prostate cancer, lung cancer, head and neck cancer, brain tumors, breast cancer and liver metastases or primary tumors, among others. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, is one of the best places to have cancer treatment abroad. IGRT_IMOR_2005_ENG.htm

· Combined treatment with 3D- conformal Radiotherapy/ IGRT IMRT + Brachytherapy either with I-125 permanent implant or HDR temporal implant, is associated with excellent 3- and 5- year disease-free survival rates in patients with clinically localized prostate cancer and high PSA levels. Data has been presented by Dr Benjamin Guix at the ASTRO (American Society for Radiotherapy and Oncology) meeting. At the same meeting, Dr Benjamin Guix and Dra Teresa Maria Lacorte, from The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, presented the results obtained at IMOR Foundation with combined treatment, with a 8-year cure rate >95% and with wxcellent Quality of life. These studies confirm Combined treatment as the best treatment for prostate cancer. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, offers the best option to have cancer treatment abroad, with the highest quality.PROSTATe_COMBINED_TREAT_2005.htm

· Dr Benjamin Guix, Director of the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, has presented in the World Brachytherapy Congress the long-term results of prostate brachytherapy for low- intermediate- and high-risk prostate cancer. Results are really spectacular, with extremely high disease-free survival and excellent quality of life. This is the best treatment for prostate cancer.

· Dr Benjamin Guix, Director of the IMOR Foundation presents the European experience in prostate brachytherapy during the World Congress of Brachytherapy, the best meeting of radiotherapy and brachytherapy.

· Gynaecological Brachytherapy considered as the standard treatment for the best treatment for gynaecologycal cancer, informed Dr Jose Antonio Lejarcegui and Professor Dr Benjamin Guix, Director of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain. IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, has the best team with the highest technology to have cancer treatment abroad GINE1-ct.htm

· Prostate Brachytherapy, increases local control at the same time that decreases side-effects in prostate cancer, as shown by a multi-center study, in which the contribution of Doctors from The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Sapin, has been very important, that has been presented by Professor Dr Benjamin Guix, Director of the IMOR Foundation at the ASCO 2005 ANNUAL MEETING (American Society for Clinical Oncology), held at Chicago (USA). This treatment offers the best disease-free survival and the best quality of life for prostate cancer.

· Brachytherapy-only, is a highly effective treatment for breast recurrences. This data have been confirmed by a trial conducted by scientifics from The IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain, presented by Professor Dr Benjamin Guix, at the GEC-ESTRO European Meeting on Brachytherapy, held at Lubeck (Germany), considered the best brachytherapy meeting. Brachytherapy is the most effective treatment for cancer.

· Brachytherapy offers more than 90 % local control in cancer. Professor Alain Gerbaulet, former Head of the Brachytherapy Unit from Institute Gustav-Roussy, made this assertion in the II International Oncological Meeting, invited by Professor Dr Benjamin Guix Director of the IMOR Foundation. Nowadays, brachytherapy offers the best results for cancer treatment. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, offers the highest technology and the most experienced team for treating cancer abroad in southern Europe.

· The last 8^th of april, IMOR Foundation, Medical Insitute for Radiotherapy and Oncology, held the Ist International Conference about Advances on Brachytherapy. World leaders in this effective and useful form of cancer treatment discussed about the recent developments and discoveries and the state of the art of this extraordinary technique. The Conference was presided by the catalan minister of Health and Social Security Mr. Xavier Pomés. By the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, presented their results Drs Antonio Arellano, Ferran Guedea and Professor Dr Benjamin Guix and the physicist Jose Ignacio Tello, about the best radiotherapy treatment.

· Brachytherapy boost useful in early breast cancer. Stage I and II breast tumors that are treated by a brachytherapy boost are doing better than those patients without boost even if they have poor prognostic factors as positive margins, extensive intraductal component or vascular invasion, according to a consensus meeting held in Barcelona. Results confirm the IMOR Foundation long-term experience, presented by Professor Dr Benjamin Guix and Jose Antonio Lejarcegui. The results confirm the boost as the best option of treatment for breast cancer. This data confirms The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain,long-term experience for breast cancer treatment abroad. Brachytherapy boost for early breast cancer.htm Brachytherapy boost in early breast cancer.

· Local relapses after conservative treatment for breast cancer, can be safely managed without mastectomy by means of brachytherapy-only, as a phase II study presented by Professor Dr Benjamin Guix Director of the IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, at the ASCO meeting has demonstrated. The brachytherapy is the best treatment for breast cancer recurrences. Trat_recidivas_mama_CAST.htm

· Temporary PSA bounces has no significant prognostic importance, as confirmed by a paper published in the International Journal of Radiation Oncology Biology and Physics, Dr Benjamin Guix Melcior explained recently. The study confirms brachytherapy, alone or in combination with IGRT-IMRT in selected cases, as the best treatment for prostate cancer. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, has the longest and highest experience in prostate cancer treatment in souther Europe, with more than 1,000 cases treated, and is the best option for cancer treatment abroad. PSA SPIKES_ANG.htm

· Partial Breast Irradiation (PBI) by Brachytherapy-only very effective treatment for early stage breast cancer. Differents reports appeared in the Journal of Clinical Oncology confirm that PBI is a very effective treatment for selected cases of low-risk small-size breast cancer, professor Dr Benjamin Guix, Director of the IMOR Foundation, Medical Institute for Radiotherapy and Oncology from Barcelona, Spain,, reported recently. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, has the world series with longer follow-up of partial breast irradiation, with the state of the art technology and best team. The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain, is the best option to have breast cancer treatment abroad. BREAST_BRACHYTHERAPY_ONLY.htm

· Professor Dr Benjamin Guix MD PhD MBA home page http://www.telefonica.net/web2/benjaminguix http://www.telefonica.net/web/bguix

· CV Professor Dr Benjamin Guix MD PhD MBA home page http://www.telefonica.net/web2/benjaminguix http://www.telefonica.net/web/bguix

· Contents about Professor Dr Benjamin Guix Melcior, in the best selection, Director of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain: Contents about Professor Dr Benjamin Guix Melcior, in the best selection, Director of The IMOR Foundation, Medical Institute for Radiotherapy and Oncology of Barcelona, Spain,: BENJAMIN GUIX_ENG04.htm

· Return to IMOR Foundation web home page: http://www.imor.org

· IMOR Foundation web site www.imor.org,

· Benjamin Guix MD PhD MBA home page, Director of the IMOR Foundation web page www.telefonica.net/web2/benjaminguix www.telefonica.net/web/bguix

· Comparison between IMRT with Lineal Accelerator and Tomotherapya, done by doctores Benjamin Guix and co-workers DOCTORES BENJAMIN GUIX Y COLS ASTRO 2005 SLIDES.ppt